Home  |  Contact

Cellosaurus ME-F2/ADM200 (CVCL_G316)

[Text version]

Cell line name ME-F2/ADM200
Accession CVCL_G316
Resource Identification Initiative To cite this cell line use: ME-F2/ADM200 (RRID:CVCL_G316)
Comments Population: Japanese.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from sampling site: Peripheral blood.
Sequence variations Gene fusion; HGNC; 1539; CBFB + HGNC; 7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
Disease Adult acute myeloid leukemia (NCIt: C9154)
Acute myeloid leukemia (ORDO: Orphanet_519)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_G313 (ME-F2)
Sex of cell Male
Age at sampling 40Y
Category Cancer cell line
Publications

PubMed=9177449; DOI=10.1038/sj.leu.2400663
Utsunomiya Y., Hasegawa H., Yanagisawa K., Fujita S.
Enhancement of mdr1 gene expression by transforming growth factor-beta1 in the new adriamycin-resistant human leukemia cell line ME-F2/ADM.
Leukemia 11:894-895(1997)

Cross-references
Other Wikidata; Q54904908
Entry history
Entry creation11-Feb-2013
Last entry update20-May-2021
Version number12